The Impact of Hyperglycemia on Risk of Severe Infections during Early Period of Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

Table 2

Multivariate analysis of risk factors for early severe infections during induction therapy (𝑛=155).

	𝑃 value	HR (95% CI)
Blood sugar ≥200 mg/dL	<0.001	7.846 (2.512–24.503)
ECOG performance status ≥2	0.001	5.801 (1.974–17.050)
ISS III	0.089	2.654 (0.862–8.171)
Lymphopenia <500/𝜇L	0.981	1.014 (0.334–3.077)
Serum creatinine ≥2 mg/dL	0.444	1.560 (0.500–4.870)

ECOG: Eastern Cooperative Oncology Group; ISS: International Staging System.